Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Subscribe to JNMT RSS feeds

PRRT

  • You have access
    Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
    Diane K. Soulek, Nic J. Mastascusa, Molly E. Martin and Stephen A. Graves
    Journal of Nuclear Medicine Technology June 14, 2022, jnmt.122.263813; DOI: https://doi.org/10.2967/jnmt.122.263813
  • You have access
    Technical Aspects and Administration Methods of 177Lu-DOTATATE for Nuclear Medicine Technologists
    Audrey B. Davis, Melanie H. Pietryka and Susan Passalaqua
    Journal of Nuclear Medicine Technology December 1, 2019, 47 (4) 288-291; DOI: https://doi.org/10.2967/jnmt.118.221846
  • You have access
    Bilateral Orbital Soft-Tissue Metastases from Renal Neuroendocrine Tumor: Successful Theranostic Application of 68Ga/177Lu-DOTATATE with Improvement of Vision
    Rahul V. Parghane and Sandip Basu
    Journal of Nuclear Medicine Technology June 1, 2019, 47 (2) 171-172; DOI: https://doi.org/10.2967/jnmt.118.217455
  • You have access
    Favorable Response of Metastatic Merkel Cell Carcinoma to Targeted 177Lu-DOTATATE Therapy: Will PRRT Evolve to Become an Important Approach in Receptor-Positive Cases?
    Sandip Basu and Rohit Ranade
    Journal of Nuclear Medicine Technology June 1, 2016, 44 (2) 85-87; DOI: https://doi.org/10.2967/jnmt.115.163527
SNMMI

© 2022 Journal of Nuclear Medicine Technology

Powered by HighWire